Sanatorio de la Trinidad - Mitre

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• High blood pressure4 trials
• Pulmonary arterial hypertension4 trials
• Epilepsy2 trials

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Enrolling by invitation2 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Actelion2 trials
• Biohaven Therapeutics Ltd.2 trials
• United Therapeutics2 trials

Running trials

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· Phase 2/3· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Actelion· Source

• Enrolling by invitation

  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  NCT03683186· Phase 3· United Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• High blood pressure1 recruiting
• Pulmonary arterial hypertension1 recruiting

Closed trials

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Actelion· Source

• Completed

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· Phase 3· United Therapeutics· Source